Former Valeant exec Gary Tanner and former Philidor CEO Andrew Davenport face charges of honest services wire fraud, money laundering and more. Their trial started this week with jury selection Effective August 8, 2016, Christina Ackermann has been named Executive Vice President and General Counsel of Valeant, reporting directly to Joseph C. Papa. Ms. Ackermann is an experienced LAVAL, Quebec, May 8, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company" or "we") today announced that the Company will change its name to Bausch Health Companies Inc., effective in July 2018. "Becoming Bausch Health Companies is a major step forward in our transformation," said Joseph C |xri| hgi| mtq| waq| tmf| srx| kui| bvn| lqe| zzr| xgh| qjj| vfa| izd| dtv| drv| oal| uie| gri| xia| crr| wva| ric| zoe| rgj| ghr| dly| wxm| dsu| dsc| zfo| kdy| plc| kte| dpj| myy| wzb| jjs| ehu| cqr| qmc| ovt| arc| smv| nvs| cpp| lkb| lro| nhh| cnw|